Patent ID: 8668901

Claim:
A method for treatment of a patient having severe and uncontrolled asthma, said method comprising: administering to the patient an inhalable corticosteroid, as a nebulized aerosol in a gas phase, wherein (a) the nebulized aerosol is administered during the inhalation phase of the patient at a rate of not more than about 20 liters per minute; (b) a total volume of at least about 0.4 liters of gas phase is administered per inhalation phase, said gas phase including the nebulized aerosol and aerosol-free air; and (c) not more than about 150 milliliters of aerosol-free air is administered before administering the nebulized aerosol; and wherein said method further includes the oral administration of a glucocorticoid at a daily dose which is not higher than about 40 milligrams of prednisolone or an equipotent dose of another glucocorticoid.